Correspondence
Response to: A randomized, open, controlled trial of tretinoin 0.05% cream vs. low-dose oral isotretinoin for the treatment of field cancerization
Angelica Misitzis MD,
Angelica Misitzis MD
Department of Dermatology, Alpert Medical School of Brown University, Providence, RI, USA
Dermatoepidemiology Unit, Veterans Affairs Medical Center, Providence, RI, USA
Search for more papers by this author Meghan Beatson BS,
Meghan Beatson BS
Department of Dermatology, Alpert Medical School of Brown University, Providence, RI, USA
Dermatoepidemiology Unit, Veterans Affairs Medical Center, Providence, RI, USA
Search for more papers by this author Martin A. Weinstock MD, PhD,
Martin A. Weinstock MD, PhD
Department of Dermatology, Alpert Medical School of Brown University, Providence, RI, USA
Dermatoepidemiology Unit, Veterans Affairs Medical Center, Providence, RI, USA
Search for more papers by this author
Angelica Misitzis MD,
Angelica Misitzis MD
Department of Dermatology, Alpert Medical School of Brown University, Providence, RI, USA
Dermatoepidemiology Unit, Veterans Affairs Medical Center, Providence, RI, USA
Search for more papers by this author Meghan Beatson BS,
Meghan Beatson BS
Department of Dermatology, Alpert Medical School of Brown University, Providence, RI, USA
Dermatoepidemiology Unit, Veterans Affairs Medical Center, Providence, RI, USA
Search for more papers by this author Martin A. Weinstock MD, PhD,
Martin A. Weinstock MD, PhD
Department of Dermatology, Alpert Medical School of Brown University, Providence, RI, USA
Dermatoepidemiology Unit, Veterans Affairs Medical Center, Providence, RI, USA
Search for more papers by this author
First published: 27 March 2019
No abstract is available for this article.
References
- 1Ianhez M, Pinto SA, Miot HA, et al. A randomized, open, controlled trial of tretinoin 0.05% cream vs. low-dose oral isotretinoin for the treatment of field cancerization. Int J Dermatol 2019; 58: 365–373.
- 2Weinstock MA, Bingham SF, Digiovanna JJ, et al. Tretinoin and the prevention of keratinocyte carcinoma (Basal and squamous cell carcinoma of the skin): a veterans affairs randomized chemoprevention trial. J Invest Dermatol 2012; 132: 1583–1590.
